Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of bacterial strain acquisition in the lung of patients with COPD: the AERIS study.
Malvisi L, Yarraguntla A, Mortier MC, Osman K, Cleary DW, Sente B, Pascal TG, Weynants V, Clarke SC, Taddei L, Wilkinson TMA, Devaster JM, Devos N; AERIS Study Group. Malvisi L, et al. Among authors: devos n. Infect Dis (Lond). 2022 Nov;54(11):784-793. doi: 10.1080/23744235.2022.2092648. Epub 2022 Jul 6. Infect Dis (Lond). 2022. PMID: 35794793
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, Magid-Slav M, Miller BE, Ostridge KK, Patel R, Sathe G, Simola DF, Staples KJ, Sung R, Tal-Singer R, Tuck AC, Van Horn S, Weynants V, Williams NP, Devaster JM, Wilkinson TMA; AERIS Study Group. Mayhew D, et al. Among authors: devos n. Thorax. 2018 May;73(5):422-430. doi: 10.1136/thoraxjnl-2017-210408. Epub 2018 Jan 31. Thorax. 2018. PMID: 29386298 Free PMC article.
UspA2 is a cross-protective Moraxella catarrhalis vaccine antigen.
Ysebaert C, Castado C, Mortier MC, Rioux S, Feron C, Di Paolo E, Weynants V, Blais N, Devos N, Hermand P. Ysebaert C, et al. Among authors: devos n. Vaccine. 2021 Sep 15;39(39):5641-5649. doi: 10.1016/j.vaccine.2021.08.002. Epub 2021 Aug 24. Vaccine. 2021. PMID: 34446318 Free article.
Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins.
Bielecka MK, Devos N, Gilbert M, Hung MC, Weynants V, Heckels JE, Christodoulides M. Bielecka MK, et al. Among authors: devos n. Infect Immun. 2015 Feb;83(2):730-42. doi: 10.1128/IAI.01815-14. Epub 2014 Dec 1. Infect Immun. 2015. PMID: 25452551 Free PMC article.
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.
Odutola A, Ota MOC, Antonio M, Ogundare EO, Saidu Y, Foster-Nyarko E, Owiafe PK, Ceesay F, Worwui A, Idoko OT, Owolabi O, Bojang A, Jarju S, Drammeh I, Kampmann B, Greenwood BM, Alderson M, Traskine M, Devos N, Schoonbroodt S, Swinnen K, Verlant V, Dobbelaere K, Borys D. Odutola A, et al. Among authors: devos n. Vaccine. 2017 May 2;35(19):2531-2542. doi: 10.1016/j.vaccine.2017.03.071. Epub 2017 Apr 4. Vaccine. 2017. PMID: 28389097 Free article. Clinical Trial.
66 results